Virus | Clinical manifestation | Assessment of fibrosis | Reversibility of pulmonary fibrosis | References |
---|---|---|---|---|
Human T-cell leukemia virus | ATL, leukemic cell infiltration, pulmonary fibrosis | CT showed ground glass opacities, bronchiectasis, centrilobular nodules, septal thickening, honeycombing and crazy-paving, suggesting the presence of pulmonary fibrosis | No mention | Assessment:[4]; reversibility: None |
Human immunodeficiency virus | Interstitial pneumonia, pulmonary fibrosis | HRCT demonstrated areas of ground glass opacification, consolidation and honeycombing, with interstitial infiltrate as the histopathologic feature | No mention | Assessment:[10]; reversibility: None |
Cytomegalovirus | Interstitial pneumonia, pulmonary fibrosis | HRCT demonstrated bilateral mixed areas of ground-glass opacity, poorly-defined centrilobular small nodules, and consolidation | No mention | Assessment:[22]; reversibility: None |
Epstein–Barr virus | Unspecific interstitial lung disease, pulmonary fibrosis | The open-lung biopsy showed uncharacteristic focal interstitial peribronchial infiltration in the left lower lobe, with histiocytes and lymphocytes as well as interstitial fibrosis and increased collagen tissue | Reversible: After 26 months, chest X-ray showed only slight interstitial markings | |
Influenza virus | ARDS, DAD bronchoalveolar pneumonia, pulmonary fibrosis | Histologic features included bronchoalveolar pneumonia, interstitial septal thickening, type II pneumonocyte hyperplasia, fibrosis and squamous metaplasia. HRCT demonstrated ground glass opacity and consolidation | Reversible: The one month follow-up CT scans showed that the fibrosis resolved | |
Avian influenza virus | ARDS, lymphopenia, pulmonary fibrosis | CT findings in H5N1 and H7N9 patients were ground-glass opacities and lobar consolidation | Reversible: The 12th month follow-up CT of patient showed only minimal residual fibrous lines | |
MERS-CoV | ARDS, multi-lobar airspace disease, pulmonary fibrosis | CT showed multi-lobar airspace disease, ground-glass opacities and pleural effusions | No mention | Assessment:[57]; reversibility: none |
SARS-CoV | ARDS, DAD, pulmonary fibrosis | The histopathological findings were extensive edema, hyaline membrane formation, alveolar collapse, and alveolar epithelial desquamation. CT showed ground-glass opacities and consolidation | Reversible: HRCT scan showed improvement of pulmonary fibrosis in one month | |
SARS-CoV-2 | ARDS, DAD, pulmonary fibrosis | Histopathological examination of the lung biopsy tissues revealed bilateral acute changes with DAD, reactive type II pneumocyte and macrophage hyperplasia, patchy inflammatory cellular infiltration and loose interstitial fibrosis | Reversible: Thin-section chest CT showed that pulmonary fibrosis developed in COVID-19 patients could reverse in about a third of the patients 120Â days after the onset |